The value of adiponectin-resistin (AR) index in newly diagnosed obesity hypertension: a case control study among Chinese adult
Autor: | Jian Hang Leng, Xi Lu, Xingyu Zhang, Hu Zhang, Wei Liu, Guo Zhong Zhang, Fen Fang Yang, Ou Wu, Jia Jia Li |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
China medicine.medical_specialty Index (economics) Physiology Newly diagnosed Body Mass Index Internal medicine Internal Medicine Humans Medicine Resistin Obesity Adiponectin business.industry Case-control study nutritional and metabolic diseases General Medicine medicine.disease Blood pressure Case-Control Studies Hypertension Insulin Resistance business Value (mathematics) hormones hormone substitutes and hormone antagonists |
Zdroj: | Clinical and Experimental Hypertension. 44:40-45 |
ISSN: | 1525-6006 1064-1963 |
DOI: | 10.1080/10641963.2021.1984500 |
Popis: | To explore the role of adiponectin-resistin (AR) index as a better indicator of obesity-related hypertension.This study continued a case control study that had finished recruiting 153 subjects divided as four characteristic groups. Fasting serum resistin levels (FSR) and Fasting serum adiponectin levels (FSA) were tested by ELISA. And, other related anthropometric clinical and metabolic data were collected. Analyzation on correlations between research index and differences between groups were done by SPSS. AR index's performance was also validated by the receiver operating characteristic (ROC) curves, the net reclassification improvement (NRI), and the integrated discrimination improvement (IDI).The AR index was defined as 1+ logThe AR index was more strongly associated with increased risk of obesity-related hypertension than the solely index of FSR or FSA and was useful for early diagnosis of obesity-related hypertension. |
Databáze: | OpenAIRE |
Externí odkaz: |